Proteasomal degradation of human peptidyl prolyl isomerase pin1-pointing phospho Bcl2 toward dephosphorylation.
暂无分享,去创建一个
[1] L. Carpenter,et al. PKCδ Is Required for Mitochondrial-dependent Apoptosis in Salivary Epithelial Cells* , 2001, The Journal of Biological Chemistry.
[2] Tianhua Niu,et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1 , 2001, The EMBO journal.
[3] T. Hsu,et al. Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis , 2001, Nature Cell Biology.
[4] M. Kirschner,et al. Pin1 acts catalytically to promote a conformational change in Cdc25. , 2001, Molecular cell.
[5] W. Gerald,et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.
[6] John Calvin Reed,et al. Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1. , 2001, Neoplasia.
[7] John C. Reed,et al. Erratum: Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1 (Neoplasia (2001) 3 (550-559) , 2001 .
[8] J. Downward,et al. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. , 2000, Journal of cell science.
[9] Hui Zhang,et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] E. Yazlovitskaya,et al. Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin* , 2000, The Journal of Biological Chemistry.
[11] G Fischer,et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. , 2000, Molecular cell.
[12] R. Craig,et al. Myeloid Cell Leukemia 1 Is Phosphorylated through Two Distinct Pathways, One Associated with Extracellular Signal-regulated Kinase Activation and the Other with G2/M Accumulation or Protein Phosphatase 1/2A Inhibition* , 2000, The Journal of Biological Chemistry.
[13] A. Schnapp,et al. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[14] S. Haldar,et al. Regulation of Bcl2 phosphorylation by stress response kinase pathway. , 2000, International journal of oncology.
[15] J. Massagué,et al. Ubiquitin-dependent degradation of TGF-β-activated Smad2 , 1999, Nature Cell Biology.
[16] Kazuhito Yamamoto,et al. BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M , 1999, Molecular and Cellular Biology.
[17] K. Lu,et al. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism , 1999, Cellular and Molecular Life Sciences CMLS.
[18] K. Umezawa,et al. Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells. , 1999, Anticancer research.
[19] P. Dent,et al. Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis. , 1999, Biochemical and biophysical research communications.
[20] S. Lowe,et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. , 1999, Science.
[21] R. K Srivastava,et al. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Korsmeyer,et al. Cell Death in Development , 1999, Cell.
[23] J. Massagué,et al. Ubiquitin-dependent degradation of TGF-beta-activated smad2. , 1999, Nature cell biology.
[24] S. Leach,et al. Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest* , 1998, The Journal of Biological Chemistry.
[25] S. Haldar,et al. Microtubule-damaging drugs triggered bcl2 phosphorylation-requirement of phosphorylation on both serine-70 and serine-87 residues of bcl2 protein. , 1998, International journal of oncology.
[26] P. Dent,et al. Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937). , 1998, Biochemical pharmacology.
[27] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[28] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[29] C. Rudin,et al. Bcl-xL is phosphorylated in malignant cells following microtubule disruption. , 1998, Cancer research.
[30] R. Perez-soler,et al. Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis* , 1998, The Journal of Biological Chemistry.
[31] S. Korsmeyer,et al. Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase , 1998, Molecular and Cellular Biology.
[32] C. Croce,et al. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. , 1998, Cancer research.
[33] M. Kirschner,et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. , 1997, Science.
[34] W. May,et al. Bcl-2 Phosphorylation Required for Anti-apoptosis Function* , 1997, The Journal of Biological Chemistry.
[35] S. Fesik,et al. Identification of a novel regulatory domain in Bcl‐xL and Bcl‐2 , 1997, The EMBO journal.
[36] N. Lenka,et al. Regulation of Murine Cytochrome Oxidase Vb Gene Expression in Different Tissues and during Myogenesis , 1997, The Journal of Biological Chemistry.
[37] C. Croce,et al. Bcl2 is the guardian of microtubule integrity. , 1997, Cancer research.
[38] T. Fojo,et al. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. , 1997, Cancer research.
[39] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[40] L. Neckers,et al. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. , 1996, Cancer research.
[41] T. Hunter,et al. A human peptidyl–prolyl isomerase essential for regulation of mitosis , 1996, Nature.
[42] C. Croce,et al. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. , 1996, Cancer research.
[43] W. B. Derry,et al. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. , 1996, Cancer research.
[44] E. White,et al. Life, death, and the pursuit of apoptosis. , 1996, Genes & development.
[45] T. Maniatis,et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.
[46] J. Cidlowski,et al. Cell cycle and apoptosis: Common pathways to life and death , 1995, Journal of cellular biochemistry.
[47] C. Croce,et al. Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Schimke,et al. Induction of apoptosis by the anti-tubulin drug colcemid: relationship of mitotic checkpoint control to the induction of apoptosis in HeLa S3 cells. , 1994, Experimental cell research.
[49] Z. Oltvai,et al. Checkpoints of dueling dimers foil death wishes , 1994, Cell.
[50] Tom Maniatis,et al. The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.
[51] J. Mitchell,et al. Cycloheximide inhibits the cytotoxicity of paclitaxel (Taxol). , 1994, Anti-cancer drugs.
[52] C. Croce,et al. Cellular localization of the bcl-2 protein and response to glucocorticoid stress. , 1994, Cell death and differentiation.
[53] A. Goldberg,et al. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. , 1994, Cell.
[54] M. Jordan,et al. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[55] John Calvin Reed,et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.
[56] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[57] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[58] R. Donehower,et al. Taxol: a novel investigational antimicrotubule agent. , 1990, Journal of the National Cancer Institute.
[59] E. Harlow,et al. Antibodies: A Laboratory Manual , 1988 .
[60] S. Korsmeyer,et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18 , 1985, Cell.
[61] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[62] P. Schiff,et al. Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[63] P. Schiff,et al. Promotion of microtubule assembly in vitro by taxol , 1979, Nature.
[64] A. van der Eb,et al. Transformation of rat cells by DNA of human adenovirus 5. , 1973, Virology.
[65] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.